A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models.
Saved in:
| Title: | A clinical SARS-CoV-2 Mpro inhibitor blocks replication of multiple enteroviruses and confers oral in vivo protection in animal models. |
|---|---|
| Authors: | Ye, Zhengyu1,2 (AUTHOR), Dai, Wenhao3,4 (AUTHOR), Zhang, Shaolin5,6 (AUTHOR), Xiang, Yingchun5,6 (AUTHOR), Wang, Jinlin3 (AUTHOR), Zhang, Yumin1,2 (AUTHOR), Cao, Wenyuan5,6 (AUTHOR), Neyts, Johan7 (AUTHOR), Li, Zuyi8 (AUTHOR), Feng, Fan1,9 (AUTHOR), Xiao, Gengfu1,2 (AUTHOR), Liu, Hong3,4 (AUTHOR) hliu@simm.ac.cn, Cao, Junyuan1,2 (AUTHOR) caojunyuan@wh.iov.cn, Zhang, Lei-ke1,2,6 (AUTHOR) zhangleike@wh.iov.cn |
| Source: | PLoS Pathogens. 3/11/2026, Vol. 22 Issue 3, p1-20. 20p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
